# Repeated Dose Phase I Study of FYU-981

> **NCT02348333** · PHASE1 · COMPLETED · sponsor: **Fuji Yakuhin Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** FYU-981, (Oral daily dosing for 7 days)
- **DRUG:** Placebo, (Oral daily dosing for 7 days)

## Key facts

- **NCT ID:** NCT02348333
- **Lead sponsor:** Fuji Yakuhin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348333, "Repeated Dose Phase I Study of FYU-981". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02348333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*